ARTICLE | Company News
Eli Lilly, Anthera deal
August 4, 2014 7:00 AM UTC
Eli Lilly granted exclusive, worldwide rights to develop and commercialize Sollpura liprotamase to Anthera. Lilly is eligible for undisclosed milestones upon product approval as well as sales milesto...